Insights - 169 Biocide Approvals Expire in 2027–2030. 75 of Those Dates Are Already Postponed

In ECHA’s biocidal active substances database, 169 approvals of 95 active substances expire between 2027 and 2030 (export of 30 October 2026). For 75 of them, the expiry date comes from a Commission decision that postponed an earlier one. The other 94 still carry their original date, and for 62 of those the renewal application falls due on or after 1 July 2026, when all approval data has to be in IUCLID.

Key takeaways

• 169 approvals (substance × product type) expire in 2027–2030, with the peak of 74 in 2028.
• Five product types account for 110 of them: PT18 (27), PT08 (23), PT02 (23), PT03 (19) and PT04 (18).
• 75 of the 169 expiry dates were already postponed by a Commission decision.
• Of the 94 approvals on their original date, 62 have a renewal application date on or after 1 July 2026, so those renewals fall under the IUCLID requirement.

Approvals expiring per year, 2027–2030

The number of approvals that expire each year, counted as active substance × product type.

58 approvals expire in 2027, 74 in 2028, 34 in 2029 and 3 in 2030. Of these, the expiry date was already postponed for 26 in 2027, 26 in 2028 and 23 in 2029.

The dates are those recorded in the database on the export date. Postponements decided later are not included.

Product types with the most expiring approvals

Approvals expiring in 2027–2030, by product type.

Insecticides and other arthropod control (PT18) lead with 27, followed by wood preservatives (PT08) and disinfectants not applied to humans or animals (PT02) with 23 each, veterinary hygiene (PT03) with 19 and food and feed area (PT04) with 18.

The count is of approvals, not of authorised products. One approval can stand behind many products.

Expiry dates already postponed

When a renewal decision cannot be taken before an approval expires, the Commission postpones the expiry date. For 75 of the 169 approvals, the legal act recorded in the database is such a decision.

Three examples from the list:

• Deltamethrin, PT18: postponed to 31 March 2028 by Decision (EU) 2025/2301, after an earlier postponement to 31 March 2026.
• DCOIT, PT08: postponed to 30 June 2028 by Decision (EU) 2025/1811; the renewal application was filed on 23 December 2021.
• IPBC, PT13: postponed from 30 November 2026 to 31 May 2029 by Decision (EU) 2026/2124; the renewal application was filed on 28 May 2025.

The IPBC record shows no renewal in the database’s assessment status. That field does not list every pending renewal, so this article does not use it to say which approvals have been applied for.

Renewal application dates per quarter

Each approval’s latest date for a renewal application, 550 days before its recorded expiry, by quarter. For postponed approvals this date is shown for reference: their applications were due against the original expiry.

For the 94 approvals on their original date, the 550-day date has passed for 52, falls within the next 12 months for 37 and is later for 5. The largest group of upcoming dates is in the second quarter of 2027, with 24 renewal deadlines; 20 of them fall on one day, 30 June 2027, for approvals that expire on 31 December 2028.

Interpretation: a passed date does not mean that no application was made. The database does not show reliably which renewals have been filed.

Where a substance is approved for several product types, the application date follows the earliest expiry among them.

Renewals under the IUCLID requirement

Since 1 July 2026, a renewal application must contain all approval data in IUCLID format, including the data from the original application. For 62 of the 94 approvals on their original date, the 550-day date falls on or after that day. Unless the application went in earlier, those renewals are prepared in IUCLID.

What this means

Postponement is common: 75 of the 169 expiry dates in 2027–2030 have already been moved. The evaluation of a renewal often takes longer than the time left on the approval.

For the approvals still on their original date, the next wave of renewal applications is due in the second quarter of 2027, built in IUCLID.

The data cannot show who is preparing an application, how far along it is, or which approvals will be left to lapse.

Methodology

• Source: ECHA, Information on biocides, active substances; full export of 30 October 2026, database last updated 29 October 2026, 945 records.
• Selection: records with approval status “Approved” and an approval end date from 1 January 2027 to 31 December 2030.
• Postponed: the legal act listed for the record is a Commission decision. Checked against the decisions for deltamethrin PT18, DCOIT PT08 and IPBC PT13.
• Application date: approval end date minus 550 days (BPR Article 13(1)). “Passed” means before 30 October 2026; “next 12 months” means up to 30 October 2027.
• All numbers are recomputed by a script from the export file.

References

1. ECHA, Information on biocides: biocidal active substances, export of 30 October 2026.
2. Regulation (EU) No 528/2012 (BPR), Article 13 and Article 14; Annex V, product types.
3. ECHA, news of 30 June 2025 on IUCLID for renewal applications.
4. Commission Implementing Decision (EU) 2025/2301 (deltamethrin, PT18).
5. Commission Implementing Decision (EU) 2025/1811 (DCOIT, PT8 and PT21).
6. Commission Decision (EU) 2026/2124 (IPBC, PT13).

Preparing an active substance renewal in IUCLID? Talk to us about a hosted IUCLID. More on IUCLID for biocides.

This article is general information, not legal or regulatory advice.